HOPE Trial
Enrolling By Invitation
18-99 years
All
Phase
N/A
30 participants needed
1 Location
Brief description of study
HOPE is a randomized clinical trial that will evaluate approaches to reducing pain and opioid use among patients with chronic pain who are receiving maintenance hemodialysis for end-stage renal disease.
The hypothesis is that pain coping skills training will be effective at reducing pain and opioid use, and that buprenorphine may provide an alternative to full agonist opioids that is acceptable and well tolerated by this patient population.
Participants will be recruited from dialysis units at Penn Medicine locations.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: renal disease,opioid,hemodialysis
-
Age: Between 18 Years - 99 Years
-
Gender: All
Updated on
01 Aug 2024.
Study ID: 843471
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com
